Moreover, IRF8 expression was extremely low or undetectable in 79% of chronic myelogeneous leukemia (CML) patients and 66% of acute myeloid leukemia (AML) patients [41]. The gene discussed is IRF8; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.